Get started
Author

F. Mattiello

OpenAlex ID: A5113810860
Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study
2014 · M. D. Alves, V. B. Ribeiro, et al. · Journal of Antimicrobial Chemotherapy · 21
Treatment‐dependence of High‐risk Gene Expression Signatures in De Novo Follicular Lymphoma
2019 · C.R. Bolen, W. Hiddemann, et al. · Hematological Oncology · 7
Prognostic Value of Pet‐ct After First‐line Immunochemotherapy for Follicular Lymphoma in the Phase Iii Gallium Study
2017 · J. Trotman, S. Barrington, et al. · Hematological Oncology · 5
PDF
End of Treatment Pet‐ct Predicts Progression‐free Survival in Dlbcl After First‐line Treatment: Results From the Phase Iii Goya Study
2017 · L. Kostakoglu, M. Martelli, et al. · Hematological Oncology · 4
PDF
Cell of Origin Combined With Cns International Prognostic Index Improves Identification of Dlbcl Patients With High Cns Relapse Risk After Initial Immunochemotherapy
2017 · M. Klanova, L.H. Sehn, et al. · Hematological Oncology · 3
PDF
S100 Treatment‐dependence of High‐risk Gene Expression Signatures in De Novo Follicular Lymphoma
2019 · C. Bolen, W. Hiddemann, et al. · HemaSphere · 2
Comparison Of Contrast-Enhanced Ct-Based Response With Pet Assessment After First-Line Therapy For Follicular Lymphoma In The Phase Iii Gallium Study
2017 · Judith Trotman, Sally F. Barrington, et al. · Haematologica · 1
Non parametric multivariate ranking methods for global performance indexes
2010 · Rosa Arboretti Giancristofaro, Livio Corain, et al. · Padua Research Archive (University of Padova) · 1
Pet‐cr as a Surrogate for Survival Outcomes in Dlbcl: a Literature Based Meta‐analysis
2019 · D.A. Berry, K.R. Broglio, et al. · Hematological Oncology
Radiomics Increase the Prognostic Value of Clinical and Pet Risk Factors in Dlbcl: Results From the Phase 3 Goya Study
2019 · S. Chauvie, F. Dalmasso, et al. · Hematological Oncology
Works count: 10
Citation count: 44
H-index: 4
I10-index: 1
Year
Topic
Type